Personalis, Inc. (PSNL) Competitors & Peers
The 5 largest companies in the same industry as Personalis, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| TMO | Peer | $675.00 | P/E 36.3RSI 73Cap 249.6 B |
| DHR | Peer | $224.49 | P/E 37.6RSI 55Cap 148.3 B |
| NTRA | Supplier | $412.56 | RSI 84Cap 59.5 B |
| A | Peer | $172.79 | P/E 30.8RSI 62Cap 44.0 B |
| IQV | Partner | $270.37 | P/E 33.7RSI 61Cap 44.5 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- NTRASupplier
Own 10-K customer-concentration disclosure: NateraInc = 30% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - MRNASupplier
Own 10-K customer-concentration disclosure: ModernaInc = 28% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - PFESupplier
Own 10-Q customer-concentration disclosure: PfizerInc = 11% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- IQVPartner
IQVIA provides contract clinical research and trial management services (CRO).
Model-inferred, unverified — treat as a lead, not evidence - AMZNSupplier
Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.
Model-inferred, unverified — treat as a lead, not evidence - PFECompetitor
Competes in development and commercialization of therapeutics for similar indications.
Model-inferred, unverified — treat as a lead, not evidence